📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Carterra

1.1 - Company Overview

Carterra Logo

Carterra

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biotechnology solutions for micro-array deposition technologies, delivering instruments and services that enable multiplexing on planar array surfaces. Offerings include LSA and LSAXT for monoclonal antibody characterization (kinetics, epitope binning), Continuous Flow Microspotter (CFM), sensor chips, kinetics and epitope software, and AI/ML in silico tools for drug discovery.

Products and services

  • LSAXT: A high-sensitivity enhanced LSA platform that yields improved data quality and sensitivity for rapid kinetics and weak binders analysis in demanding applications
  • LSA: A high-throughput monoclonal antibody characterization platform combining flow printing microfluidics with surface plasmon resonance detection to deliver detailed antibody kinetics and epitope binning on planar array surfaces
  • Kinetics Software: Scalable software that analyzes kinetic interactions, processing and visualizing large data sets generated from up to 1152 samples simultaneously

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Carterra

Algenex Logo

Algenex

HQ: Spain Website
  • Description: Provider of vector-based technologies to manufacture recombinant proteins via a baculovirus expression vector system, with applications in vaccines, diagnostic reagents, crystallography, HTS and therapeutic molecules. Offers CrisBio, animal vaccine development/production, and biocomponents for diagnostic and therapeutic markets in human and animal health.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Algenex company profile →
Reach Separations Logo

Reach Separations

HQ: United Kingdom Website
  • Description: Provider of chiral and achiral separation services, discovery chromatography, large-scale SFC, impurity isolations, and analytical services, including EE determinations; purification of hundreds of grams of racemate using preparative HPLC/SFC and large-scale SFC with automated screening and evaporation; LC-MS/SFC-MS method development, orthogonal purity analysis, multi-component resolutions, reference standard generation; MS-MS/NMR elucidation; QC purity checks and stability studies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Reach Separations company profile →
Grundium Logo

Grundium

HQ: Finland Website
  • Description: Provider of smart, portable digital microscope slide scanners leveraging state-of-the-art mobile technology for medical and research specialists. Offerings include Ocus 20 (20x) for fast imaging, intraoperative frozen sections and general pathology; Ocus 40 (40x) for high-resolution histopathology, tumor grading and cytology; and upcoming Ocus M 40 with four-slide tray, upgraded processor and 2TB storage.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Grundium company profile →
InSphero Logo

InSphero

HQ: Switzerland Website
  • Description: Provider of organotypic biological in vitro 3D microtissues and microtissue-based assays for biochemical compound screening and predictive drug testing, offering human prostate and mammary carcinoma and rat liver microtissues, plus services including compound toxicity testing, cell-invasion assays, and stem-cell research.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full InSphero company profile →
Ncardia Logo

Ncardia

HQ: The Netherlands Website
  • Description: Provider of iPSC-based drug discovery platforms and predictive human cellular assay systems to expedite drug discovery from hit identification to lead optimization. Offers Ncyte Smooth Muscle Cells, Astrocytes, Endothelial Cells, Neural Mix, and vCardiomyocytes for in vitro modeling, safety and efficacy testing, cardiovascular and neural screening, pharmacology, toxicity, electrophysiology, and disease modeling.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ncardia company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Carterra

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Carterra

2.2 - Growth funds investing in similar companies to Carterra

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Carterra

4.2 - Public trading comparable groups for Carterra

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Carterra

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Carterra

What does Carterra do?

Carterra is a provider of biotechnology solutions for micro-array deposition technologies, delivering instruments and services that enable multiplexing on planar array surfaces. Offerings include LSA and LSAXT for monoclonal antibody characterization (kinetics, epitope binning), Continuous Flow Microspotter (CFM), sensor chips, kinetics and epitope software, and AI/ML in silico tools for drug discovery.

Who are Carterra's competitors?

Carterra's competitors and similar companies include Algenex, Reach Separations, Grundium, InSphero, and Ncardia.

Where is Carterra headquartered?

Carterra is headquartered in United States.

How many employees does Carterra have?

Carterra has 1,000 employees 🔒.

When was Carterra founded?

Carterra was founded in 2010 🔒.

What sector and industry vertical is Carterra in?

Carterra is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Carterra

Who are the top strategic acquirers in Carterra's sector and industry

Top strategic M&A buyers and acquirers in Carterra's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Carterra?

Top strategic M&A buyers groups and sectors for Carterra include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Carterra's sector and industry vertical

Which are the top PE firms investing in Carterra's sector and industry vertical?

Top PE firms investing in Carterra's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Carterra's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Carterra's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Carterra's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Carterra include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Carterra's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Carterra?

The key public trading comparables and valuation benchmarks for Carterra include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Carterra for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Carterra with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Carterra's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Carterra with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Carterra's' sector and industry vertical?

Access recent funding rounds and capital raises in Carterra's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Carterra